Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Ceriani

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Hematological Oncology|October 29, 2021
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysisLuca Ceriani, Lisa Milan, Luciano Cascione, et al.
Thyroid : Official Journal of the American Thyroid Association|March 14, 2019
Role of <sup>18</sup>F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer PatientsArnoldo Piccardo, Pierpaolo Trimboli, Matteo Puntoni, et al.
Blood Advances|March 21, 2020
SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic modelLuca Ceriani, Giuseppe Gritti, Luciano Cascione, et al.
Blood|May 4, 2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphomaLuca Ceriani, Lisa Milan, Maurizio Martelli, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell LymphomaLuca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2022
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic IndexN George Mikhaeel, Martijn W Heymans, Jakoba J Eertink, et al.
Blood|June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaLuca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Haematologica|May 15, 2025
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET responseJakoba J Eertink, Martijn W Heymans, Sanne E Wiegers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 StudyMaurizio Martelli, Luca Ceriani, Emanuele Zucca, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Hematological Oncology|October 29, 2021
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysisLuca Ceriani, Lisa Milan, Luciano Cascione, et al.
Thyroid : Official Journal of the American Thyroid Association|March 14, 2019
Role of <sup>18</sup>F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer PatientsArnoldo Piccardo, Pierpaolo Trimboli, Matteo Puntoni, et al.
Blood Advances|March 21, 2020
SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic modelLuca Ceriani, Giuseppe Gritti, Luciano Cascione, et al.
Blood|May 4, 2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphomaLuca Ceriani, Lisa Milan, Maurizio Martelli, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell LymphomaLuca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2022
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic IndexN George Mikhaeel, Martijn W Heymans, Jakoba J Eertink, et al.
Blood|June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaLuca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Haematologica|May 15, 2025
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET responseJakoba J Eertink, Martijn W Heymans, Sanne E Wiegers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 StudyMaurizio Martelli, Luca Ceriani, Emanuele Zucca, et al.
Pageof 14